Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
139K
-
Shares change
-
+91.1K
-
Total reported value, excl. options
-
$431K
-
Value change
-
+$283K
-
Number of buys
-
6
-
Price
-
$3.13
Significant Holders of Arcadia Biosciences, Inc. - COM (RKDA) as of Q4 2023
13 filings reported holding RKDA - Arcadia Biosciences, Inc. - COM as of Q4 2023.
Arcadia Biosciences, Inc. - COM (RKDA) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 139K shares
.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (97.3K shares), VANGUARD GROUP INC (14K shares), STATE STREET CORP (12.1K shares), Virtu Financial LLC (11.4K shares), Tower Research Capital LLC (TRC) (2.88K shares), JPMORGAN CHASE & CO (508 shares), MORGAN STANLEY (207 shares), BlackRock Inc. (38 shares), GROUP ONE TRADING, L.P. (18 shares), and WELLS FARGO & COMPANY/MN (9 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.